Tapping into thinking through mobile apps in schizophrenia
Not Applicable
- Conditions
- Health Condition 1: F20- Schizophrenia
- Registration Number
- CTRI/2023/08/056708
- Lead Sponsor
- Beth Israel Deaconess Medical Center (BIDMC)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Diagnosis of a psychotic disorder
2.Severity of symptoms at least to a mild degree on The Positive and Negative Syndrome Scale (PANSS) over the past 3 months
3.If prescribed, a stable medication dosage for at least the past month (self-report and clinical records)
Exclusion Criteria
1.Substance use disorder during the last 3 months
2.Benzodiazepines in the last 4 weeks
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess changes in micro cognitive & contextual momentary performance metrics as correlated to changes in functioning, positive symptoms of schizophrenia, and any changes in the MATRICS Consensus Cognitive Battery (MCCB)Timepoint: 0,90,and180days
- Secondary Outcome Measures
Name Time Method To assess changes in micro cognitive & contextual momentary performance in relation to functioning and psychotic-like experiencesTimepoint: 0,90,and180days